Cullinan Oncology Inc. (CGEM) PT Lowered to $49 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CGEM Hot Sheet
Price: $20.34 +3.56%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Edward White lowered the price target on Cullinan Oncology Inc. (NASDAQ: CGEM) to $49.00 (from $50.00) while maintaining a Buy rating.
You May Also Be Interested In
- Zipalertinib combo meets Phase 3 trial goal in lung cancer study
- Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
